{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-097591","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.579827+00:00","generated_at":"2026-05-17T04:28:45.889677+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Humacyte prices $60M registered direct offering of common stock and warrants","bullets":["Raised $60.0M via sale of 28.4M shares and warrants to purchase 28.4M shares at $2.11 per unit.","Warrants exercisable at $2.11, become exercisable 180 days after issuance, expire April 7, 2031.","Offering oversubscribed with institutional investors; expected to close October 8, 2025.","D. Boral Capital acting as exclusive placement agent; fee equal to 5.75% of gross proceeds.","Offered under effective shelf registration statement (File No. 333-290231) declared effective Sept 22, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-097591","json":"https://secwatch.observer/filing/0001104659-25-097591.json","markdown":"https://secwatch.observer/filing/0001104659-25-097591.md","text":"https://secwatch.observer/filing/0001104659-25-097591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000110465925097591/0001104659-25-097591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000110465925097591/tm2528189d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:28:45.889677+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}